Policy | August 27, 2024
India's bioeconomy to reach US $300 billion by 2030: Dr. Jitendra Singh
The new bioeconomy policy rolled out by the Modi government is set to place India as a global leader in the years to come
The new bioeconomy policy rolled out by the Modi government is set to place India as a global leader in the years to come
Launch of 20 new medicines expected by 2030
Expanded collaboration with Vanguard Renewables aims to significantly increase the productivity of US renewable natural gas generation
Honeywell Solstice Air is a hydrofluoroolefin (HFO) propellant in clinical development today for pMDIs
Teva will leverage Honeywell’s ‘Energy as a Service’ (EaaS) model
Good momentum in commercial CDMO business
New reforestation projects in Brazil, India, Vietnam, Ghana and Rwanda in addition to existing projects including in Australia and Indonesia
At commercial scale, Bluestem's patent pending technologies will reduce carbon emission by an estimated 75% or more and be cost-competitive with petroleum based chemicals
_256_384.png)
Amongst the first pharmaceutical companies in India and Asia to be recognised for adopting advanced fourth industrial revolution technologies to digitally transform operations
The company now exceeds the sector benchmark for its overall ESG rating and for all three measures
Subscribe To Our Newsletter & Stay Updated
